
flurouracil. Clinical examination which was done on  carcinomas of the bulbomembranous urethra are 
completion  of   the  chemotherapy  treatment  of squamous cell origin in 80%, of transitional cell 
revealed marked decrease in the size of the mass,  origin  in  10%,  and  adenocarcinoma  or 
3
although still palpable, and closure of the scrotal  undifferentiated in 10% .
sinus. Staging  of   the  tumour  includes  clinical 
Repeat CT scan confirmed the clinical findings  examination, cystoscopy, and bimanual palpation to 
and did not detect any abdominal lymphadenopathy  evaluate  the  extent  of  local  involvement  of  the 
(Figure 3).  The patient  was scheduled for  radical  tumor. Transurethral or needle biopsy of the lesion, 
penectomy, scrotectomy, cystoprostatectomy, pelvic  and of the prostate if indicated, is also performed as 
lymphadenectomy  and  urinary  diversion  (  ileal  part of  the staging (Table 1). 
conduit ). The mass was excised with difficulty, as it 
was attached to the iliac bone and to the rectum.  Table 1.  Clinical-pathologic staging for 
Accidental  rectal  injury  was  encountered  during  urethral cancer
excision of the bladder and was primarily repaired 
using vicryl and anal dilatation. Figures 4 and 5 show 
the external genitalia  and the  excised bladder . The 
testes  were  inserted  into  an  inguinal  pouch 
bilaterally. The  perineal wound was left open  for 
future skin graft.
The  patient  developed  rectal  fistula  to  the 
perineal  wound.  This  closed  in  10  days  of  low 
residue diet. The perineal wound was subsequently 
covered with skin graft.  
The  pathological  specimen  showed  a  locally 
advanced high grade transitional cell carcinoma of 
the  urethra  with  local  extension  to  the  corpus 
cavernosum.  The  surgical  margin  was  free  of 
tumour  and  the  lymph  nodes  showed  reactive 
lymphadenopathy.  There  was  no  evidence  of 
squamous cell cancer in the specimen.  In addition, a 
focal prostatic adenocarcinoma with Gleason score 
of 6 (3+3) was demonstrated within the prostate 
specimen. 
Due to the nature of  the tumour, the patient was 
administered  adjuvant  chemo-radiotherapy  using 
Urethral cancer staging in accordance with the criteria 
Gemcitabin and Cisplatinum with local radiation to  outlined  by  the  American  Joint Committee  on  Cancer 
the pelvis and the perineum. The patient remains  Staging System
disease free six months post treatment.
No consensus has been reached regarding the 
Discussion optimal therapeutic approach for urethral tumours 
due  to  the  small  number  of  patients  treated  at 
The histologic subtype of urethral cancer varies by  individual  institutions.  The  overall  management 
anatomic  location.  Carcinomas  of  the  prostatic  depends on the site and the stage of the tumor. 
urethra are of transitional cell origin in 90% and of  Distal urethral tumours are usually of low stage 
squamous  cell  origin  in  10%,  carcinomas  of  the  and are amenable to local excision with good overall 
penile urethra are of squamous cell origin in 90%  prognosis.  On  the  contrary,  proximal  urethral 
and  of   transitional  cell  origin  in  10%,  and  tumours  present  with  higher  stage  require 
Port Harcourt Medical Journal  2007; 1:  208-211                                                                                                                      210    
Local advanced transitional cell cancer                                                                      E.H. Abdel Goad, T. De Bastiani and S. Ramksoon 
Tx
 
T0
 
Ta
 
Primary tumor cannot be assessed 
No evidence of primary tumor
Noninvasive papillary, polypoid, or 
verrucous carcinoma
Tis
 
T1
 
Carcinoma in situ
Tumor invades subepithelial connective
tissue
 
T2
 
Tumor invades any of the following :
corpus spongiosum, prostate, periurethral 
muscle
 
T3
 
Tumor invades any of the following:
corpus cavernosum, beyond prostate 
capsule, anterior vagina, bladder neck
T4
 
Tumor invades other adjacent organs
Regional 
lymph nodes (N)
   
Nx
 
Regional lymph nodes cannot be assessed
N0
 
No regional lymph nodes metastasis
N1
 
Metastasis in a single lymph node, 2 cm 
or less  in greatest dimension
N2 Metastasis in a single lymph node, more 
than 2 cm in greatest dimension, or in 
multiple lymph nodes
Distant 
metastasis (M)
Mx Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metatasis
Primary tumor    (T)  (men and women)